Fas engagement induces neurite growth through ERK activation and p35 upregulation

Nature Cell Biology

Volumn 5, Issue 2, 2003, Pages 118-125

  Desbarats, Julie ^a,b,c   Birge, Raymond B ^b,d   Mimouni Rongy, Manuelle ^a   Weinstein, David E ^e   Palerme, Jean Sébastien ^a   Newell, M Karen ^c  

^a MCGILL UNIVERSITY   (Canada)

^b ROCKEFELLER UNIVERSITY   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE; NEURITE PROMOTING FACTOR; PROTEIN ANTIBODY; PROTEIN P35; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CELL FUNCTION; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; CONVALESCENCE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NERVE FIBER GROWTH; NERVE INJURY; NERVE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN DEFICIENCY; PROTEIN FAMILY; REVIEW; SCIATIC NERVE; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIGENS, CD95; CULTURE TECHNIQUES; ENZYME ACTIVATION; FLOW CYTOMETRY; GANGLIA, SPINAL; HUMANS; LOCOMOTION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NERVE REGENERATION; NERVE TISSUE PROTEINS; NEURITES; NEURONS; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; SCIATIC NERVE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED; UP-REGULATION;

ANIMALIA;

EID: 0037321075     PISSN: 14657392     EISSN: None     Source Type: Journal    
DOI: 10.1038/ncb916     Document Type: Review

References (50)

1. Yonehara, S., Ishii, A. & Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756 (1989).
2. Trauth, B. C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989).
3. Shinohara, H., Yagita, H., Ikawa, Y. & Oyaizu, N. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase. Cancer Res. 60, 1766-1772 (2000).
4. Gomez, C. et al. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J. Neurosci. Res. 63, 421-428 (2001).
5. Becher, B., D'Souza, S. D., Troutt, A. B. & Antel, J. P. Fas expression on human fetal astrocytes astrocytes without susceptibility to Fas-mediated cytotoxicity. Neurosciences 84, 627-634 (1998).
6. Raoul, C., Henderson, C. E. & Pettmannm, B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J. Cell Biol. 147, 1049-1062 (1999).
7. Raoul, C. et al. Motoneuron death triggered by a specific pathway downstream of Fas. Pontentiation by ALS-linked SOD1 mutations. Neuron 35, 1067-1083 (2002).
8. Matsushita, K. et al. Fas receptor and neuronal cell death after spinal cord ischemia. J. Neurosci. 20, 6879-6887 (2000).
9. Cheema, Z. F. et al. Fas/Apo (apoptosis)-1 and associated proteins in the differentiating cerebral cortex: induction of caspase-dependent cell death and activation of NF-κB. J. Neurosci. 19, 1754-1770 (1999).
10. Alderson, M. R. et al. Fas transduces activation signals in normal human T lymphocytes. J. Exp. Med. 178, 2231-2235 (1993).
11. Owen-Schaub, Meterissian, S. & Ford, R. J. Fas/APO-1 expression and function on malignant cells of hematologic and non-hematologic origin. J. Immunother. 14, 234-241 (1993).
12. Alderson, M. R. et al. Regulation of apoptosis and T cell activation by Fas-specific mAb. Int. Immunol. 6, 1799-1806 (1994).
13. Freiberg, R. A. et al. Fas signal transduction triggers proliferation or apoptosis in human fibroblasts. J. Invest. Dermatol. 108, 215-219 (1997).
14. + T cell responses to Fas (CD95) engagement. Proc. Natl Acad. Sci. USA 96, 8104-8109 (1999).
15. Desbarats, J. & Newell, M. K. Fas engagement accelerates liver regeneration after partial hepatectomy. Nature Med. 6, 920-923 (2000).
16. Tsutsui, H. et al. Caspase-1 independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359-367 (1999).
17. Nagata, S. Apotosis by death factor. Cell 88, 355-365 (1997).
18. Medema, J. P. et al. FLICE is activated by association with the CD95 death-inducing signalling complex (DISC). EMBO J. 16, 2794-2804 (1997).
19. Irmler, M. et al. Inhibition of death receptor signals by cellular FLIP. Nature 388, 190-195 (1997).
20. Fukunaga, K. & Miyamoto, E. Role of MAP kinase in neurons. Mol. Neurobiol. 16, 79-95 (1998).
21. Holmstrom, T. et al. MAPK/ERK signalling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. EMBO J. 19, 5418-5428 (2000).
22. Kataoka, T. et al. The caspase-8 inhibitor FLIP promotes activation of NF-κB and ERK signalling pathways. Curr. Biol. 10, 640-648 (2000).
23. Kury, P., Stoll, G. & Muller, H. W. Molecular mechanisms of cellular interaction in peripheral nerve regeneration. Curr. Opin. Neurobiol. 14, 635-639 (2001).
24. Levi-Montalcini, R., Meyer, H. & Hamburger, V. In vitro experiments on the effects of mouse sarcoma 180 and 37 on the spinal and sympathetic ganglia of the chick embryo. Cancer Res. 14, 49-57 (1954).
25. Lonze, B.E., Riccio, A., Cohen, S. & Ginty, D. D. Apoptosis, axonal growth defects, and degeneration of peripheral neurons in mice lacking CREB. Neuron 34, 371-385 (2002).
26. Chen, M. S. et al. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature 403, 434-439 (2000).
27. Ledda, F., Paratcha, G. & Ibanez, C. F. Target-derived GFRα1 as an attractive guidance signal for developing sensory and sympathetic axons via acitivation of Cdk5. Neuron 36, 387-401 (2002).
28. Levi-Montalcini, R. & Angeletti, P. U. Essential role of the nerve growth factor in survival and maintenance of dissociated sensory and sympathetic embryonic nerve cells in vitro. Dev. Biol. 7, 653-659 (1963).
29. Qian, X., Riccio, A., Zhang, Y. & Ginty, D. D. Identification and characterization of novel substrates of Trk receptors in developing neurons. Neuron 21, 1017-1029 (1998).
30. Cowley, S., Paterson, H., Kemp, P. & Marshall, C. J. Activation of MAP kinase kinase in necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77, 841-852. (1994).
31. Pang, L., Sawada, T., Decker, S. J. & Saltiel, A. R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nervef growth factor. J. Biol. Chem. 270, 13585-13588 (1995).
32. Harada, T., Morooka, T., Ogawa, S. & Nishida, E. ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nature Cell Biol. 3, 453-459 (2001).
33. Nikolic, M., Dudek, H., Kwon, Y. T., Ramos, Y. F. & Tsai, L. S. The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. Genes Dev. 10, 816-825 (1996).
34. Biedler, J. L. Roffler-Tarlov, S., Schachner, M. & Freedman, L. S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38, 3751-3757 (1978).
35. Ju, S. T. et al. Fas (CD95)/FasL interactions required for programmed cell death after T-cell activattion. Nature 373, 345-348 (1995).
36. Kimura, M. & Matsuzawa, A. Autoimmunity in mice bearing lpr.cg: a novel mutant gene. Int. Rev. Immunol. 11, 193-210 (1994).
37. Chinnaiyan, A. M., O'Rourke, K. Tewari, M. & Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
38. Eberstadt, M., Huang, B., Olejniczak, E. T. & Fesik, S. W. The lymphoproliferation mutation in Fas locally unfolds the Fas death domain. Nature struct. Biol. 4, 983-985 (1997).
39. Adachi, M., Watanabe-Fukunaga, R. & Nagata, S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc. Natl Acad. Sci. USA 90, 1756-1760 (1993).
40. De Medinaceli, L., Freed, W. J. & Wyatt, R. J. An index of the functional condition of rat sciatic nerve based on measurement made from walking tracks. Exp. Neurol. 77, 634-643 (1982).
41. Sakic, B. et al. Progressive atrophy of pyramidal neuron dentrites in autoimmune MRL-lpr mice. J. Neuroimmunol. 87, 162-170 (1998).
42. Martin-Villalba, A. et al. CD95 ligand (Fas-L/APO-IL) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817 (1999).
43. Newell, M. K. et al. Does the oxidative/glycolytic ratio determine proliferation or death in immune recognition? Ann. NY Acad. Sci. 887, 77-82 (1999).
44. Wohlleben, G. et al. Regulation of Fas and FasL expression on rat Schwann cells. Glia 30, 373-381. (2000).
45. Schwartz, M., Moalem, G., Leibowitz-Amit, R. Innate and adaptive immune responses can be beneficial for CNs repair. Trends Neurosci. 22, 295-299 (1999).
46. Biancone, L. et al. Development of inflammatory angiogenesis by local stimulation of Fas in vivo. J. Exp. Med. 186, 147-152 (1997).
47. Tran, S. E., Holmstron, T. H., Ahonen, M., Kahari, V. M. & Eriksson, J. E. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276, 16484-16490 (2001).
48. Wilson, D., Alessandrini, A,. & Budd, R. MEKI activation rescues Jurkat T cells from Fas-induced apoptosis. Cell. Immunol. 194, 67-77 (1999).
49. Wosik, K., Becher, B., Ezman, A., Nalbantoglu, J. & Antel, J. P. Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes. Glia 33, 217-224 (2001).
50. + T cells. Nature Med. 4, 1377-1381 (1998).